IFNA17 and Aicardi-Goutieres syndrome: We used Simoa to detect IFN-α in the serum and cerebral spinal fluid (CSF) across a spectrum of non-interferonopathic and interferonopathic diseases and showed that the central nervous system (CNS) is the primary source of neurotoxic IFN-α in AGS.